Editorial Staff

Clinical Editor
Morton Kern, MD
Executive Editor
Laurie Gustafson
Managing Editor
Rebecca Kapur
Production Manager
Elizabeth Vasil

Editorial Correspondence

Rebecca Kapur, Managing Editor, Cath Lab Digest
HMP Communications, 70 E. Swedesford Rd
Suite 100, Malvern PA 19355
Telephone: (440) 717-0418

Fax: (866) 896-8762
Email: rkapur@hmpglobal.com

March 2003

|
Volume 11 Issue 3
What if you read comments like: Excellent breakout sessions; Symposium and entertainment were excellent; SICP should be commended; Very well-planned and thought out; I’ve attended these type of meetings in Cincinnati, Texas, Tennessee, and…
Abbott Vascular Visit Abbott Vascular at ACC Booth # 2403 For more information, call (800) 222-6883 or go to www.perclose.com. Amersham Health Visit Amersham Health at ACC Booth # 3048 For more information, call (609) 514-6000 or go to www.ame…
Patient Follow Up Our lab is going to start following patients after discharge to home. The plan is to call patients at home and ask them various questions about their post-hospital recovery period. We’d like to know what other labs do in regards to…
March 27 - 29 14th Annual ACCA Cardiovascular Administrators’ Management Conference American College of Cardiovascular Administrators is a specialty group of the American Academy of Medical Administrators Managing the Winds of Change: Evolution, Eth…
The following Email Discussion Group was sponsored by the Society for Invasive Cardiovascular Professionals (SICP). Does your hospital plan on stocking drug-eluting stents? If yes, will you have strict criteria for usage? Patient Selection Criter…
Safety and Efficacy of Cutting Balloon Angioplasty:The Mayo Clinic Experience James L. Orford, MBChB, MPH, Panayotis Fasseas, MD, Ali E. Denktas, MD, LaVon Hammes, Kirk N. Garratt, MD, Peter B. Berger, MD, David R. Holmes, MD, Gregory W. Barsness, MD…
Boston Scientific Announces European Launch of Its TAXUS Paclitaxel-Eluting Stent System Boston Scientific Corporation announced that it has initiated the launch of its TAXUS® paclitaxel-eluting stent system in Europe and other international markets…
HIV Drugs Don’t Increase Heart Risk Fears that the drugs used to treat people infected with HIV cause an increased risk of heart attack and stroke appear to be unfounded, at least over the short term, researchers report. While it is possible there…
Such could be applied to the success and failure of many medical technology, biotech, and life sciences companies. It’s often not one major breakthrough that usually guarantees the success of a new venture, as some may think. Success often lies in th…